In addition, CCL2 in hepatocellular carcinoma (HCC) models attracts CCR2+ myeloid cells that stimulate SC clearance via immunosurveillance but can promote the growth of already established HCC cells by inhibiting NK cell–mediated clearance of cancer cells (115). Here, CCR2 is linked to hepatocellular carcinoma.